Key result
Real-world evidence in non-valvular atrial fibrillation complements randomized controlled trials by evaluating stroke prevention strategies outside of artificial clinical scenarios.
Answers are grounded in this paper and cite their sources.
Discusses the role of real-world evidence compared to randomized controlled trials for stroke prevention in non-valvular atrial fibrillation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Gregory Y.H. Lip (2016) studied this question. Real-world evidence in non-valvular atrial fibrillation complements randomized controlled trials by evaluating stroke prevention strategies outside of artificial clinical scenarios.
Synapse has enriched 10 related papers. Consider them for comparative context: